vs

Side-by-side financial comparison of ADC Therapeutics SA (ADCT) and HOME BANCORP, INC. (HBCP). Click either name above to swap in a different company.

HOME BANCORP, INC. is the larger business by last-quarter revenue ($38.2M vs $23.1M, roughly 1.7× ADC Therapeutics SA). Over the past eight quarters, ADC Therapeutics SA's revenue compounded faster (13.7% CAGR vs 7.4%).

ADC Telecommunications, Inc. was a communications company in Eden Prairie, Minnesota, a southwest suburb of Minneapolis. It was acquired by TE Connectivity in December 2010 and ceased to exist as a separate entity. ADC products were sold by CommScope after it acquired the Broadband Network Solutions business unit from TE Connectivity in August 2015.

U.S. Bancorp is an American multinational banking institution headquartered in Minneapolis, Minnesota and incorporated in Delaware. It is the 5th-largest bank in the United States as of 2025. As the largest bank in the Midwestern United States, it is considered systemically important by the Financial Stability Board. It is the parent company of its primary operating entity, U.S. Bank National Association, which does business as U.S. Bank. The company provides banking, investment, mortgage, tr...

ADCT vs HBCP — Head-to-Head

Bigger by revenue
HBCP
HBCP
1.7× larger
HBCP
$38.2M
$23.1M
ADCT
Faster 2-yr revenue CAGR
ADCT
ADCT
Annualised
ADCT
13.7%
7.4%
HBCP

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
ADCT
ADCT
HBCP
HBCP
Revenue
$23.1M
$38.2M
Net Profit
$11.4M
Gross Margin
Operating Margin
-77.7%
Net Margin
29.7%
Revenue YoY
36.4%
Net Profit YoY
EPS (diluted)
$0.04
$1.45

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ADCT
ADCT
HBCP
HBCP
Q1 26
$38.2M
Q4 25
$23.1M
$38.0M
Q3 25
$15.8M
$37.8M
Q2 25
$18.1M
$37.1M
Q1 25
$17.4M
$35.8M
Q4 24
$16.9M
$35.2M
Q3 24
$18.0M
$34.1M
Q2 24
$17.0M
$33.1M
Net Profit
ADCT
ADCT
HBCP
HBCP
Q1 26
$11.4M
Q4 25
$11.4M
Q3 25
$-41.0M
$12.4M
Q2 25
$-56.6M
$11.3M
Q1 25
$-38.6M
$11.0M
Q4 24
$9.7M
Q3 24
$-44.0M
$9.4M
Q2 24
$-36.5M
$8.1M
Operating Margin
ADCT
ADCT
HBCP
HBCP
Q1 26
Q4 25
-77.7%
38.2%
Q3 25
-196.6%
41.1%
Q2 25
-244.1%
38.2%
Q1 25
-163.5%
38.6%
Q4 24
-191.8%
34.0%
Q3 24
-197.4%
34.3%
Q2 24
-170.5%
30.4%
Net Margin
ADCT
ADCT
HBCP
HBCP
Q1 26
29.7%
Q4 25
30.0%
Q3 25
-260.1%
32.7%
Q2 25
-313.2%
30.6%
Q1 25
-221.8%
30.7%
Q4 24
27.5%
Q3 24
-244.1%
27.7%
Q2 24
-214.6%
24.5%
EPS (diluted)
ADCT
ADCT
HBCP
HBCP
Q1 26
$1.45
Q4 25
$0.04
$1.46
Q3 25
$-0.30
$1.59
Q2 25
$-0.50
$1.45
Q1 25
$-0.36
$1.37
Q4 24
$-0.26
$1.21
Q3 24
$-0.42
$1.18
Q2 24
$-0.38
$1.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ADCT
ADCT
HBCP
HBCP
Cash + ST InvestmentsLiquidity on hand
$261.3M
$223.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$-185.8M
$444.4M
Total Assets
$323.1M
$3.6B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ADCT
ADCT
HBCP
HBCP
Q1 26
$223.5M
Q4 25
$261.3M
Q3 25
$234.7M
Q2 25
$264.6M
Q1 25
$194.7M
Q4 24
$250.9M
Q3 24
$274.3M
Q2 24
$300.1M
Stockholders' Equity
ADCT
ADCT
HBCP
HBCP
Q1 26
$444.4M
Q4 25
$-185.8M
$435.1M
Q3 25
$-238.2M
$423.0M
Q2 25
$-199.2M
$408.8M
Q1 25
$-238.2M
$402.8M
Q4 24
$-202.6M
$396.1M
Q3 24
$-171.9M
$393.5M
Q2 24
$-131.7M
$375.8M
Total Assets
ADCT
ADCT
HBCP
HBCP
Q1 26
$3.6B
Q4 25
$323.1M
$3.5B
Q3 25
$289.8M
$3.5B
Q2 25
$321.6M
$3.5B
Q1 25
$272.5M
$3.5B
Q4 24
$322.0M
$3.4B
Q3 24
$349.1M
$3.4B
Q2 24
$371.8M
$3.4B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ADCT
ADCT
HBCP
HBCP
Operating Cash FlowLast quarter
$-31.1M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ADCT
ADCT
HBCP
HBCP
Q1 26
Q4 25
$-31.1M
$54.5M
Q3 25
$-29.6M
$21.5M
Q2 25
$-24.1M
$8.7M
Q1 25
$-56.3M
$12.6M
Q4 24
$-21.9M
$48.7M
Q3 24
$-25.0M
$17.6M
Q2 24
$-32.8M
$15.0M
Free Cash Flow
ADCT
ADCT
HBCP
HBCP
Q1 26
Q4 25
$44.3M
Q3 25
$20.7M
Q2 25
$7.9M
Q1 25
$-56.6M
$8.7M
Q4 24
$-21.9M
$44.7M
Q3 24
$-25.3M
$17.0M
Q2 24
$-32.9M
$13.4M
FCF Margin
ADCT
ADCT
HBCP
HBCP
Q1 26
Q4 25
116.5%
Q3 25
54.6%
Q2 25
21.3%
Q1 25
-325.2%
24.3%
Q4 24
-129.8%
126.9%
Q3 24
-140.2%
49.8%
Q2 24
-193.0%
40.3%
Capex Intensity
ADCT
ADCT
HBCP
HBCP
Q1 26
Q4 25
0.0%
26.7%
Q3 25
0.0%
2.2%
Q2 25
0.0%
2.3%
Q1 25
1.5%
10.8%
Q4 24
0.5%
11.5%
Q3 24
1.2%
1.9%
Q2 24
0.2%
4.9%
Cash Conversion
ADCT
ADCT
HBCP
HBCP
Q1 26
Q4 25
4.78×
Q3 25
1.74×
Q2 25
0.77×
Q1 25
1.15×
Q4 24
5.04×
Q3 24
1.87×
Q2 24
1.84×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ADCT
ADCT

Segment breakdown not available.

HBCP
HBCP

Net Interest Income$34.5M90%
Noninterest Income$3.7M10%

Related Comparisons